Literature DB >> 9176105

Secretion of cytokines by natural killer cells primed with interleukin-2 and stimulated with different lipoproteins.

J B De Sanctis1, I Blanca, N E Bianco.   

Abstract

Natural killer (NK) cells were shown to secrete differentially interleukins (IL), IL-1 alpha, IL-1 beta, IL-2, IL-8, interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha), granulocyte-macrophage colony-stimulating factor (GM-CSF), and leukaemia inhibitory factor (LIF) upon stimulation with optimal concentrations of chylomicrons (CM), very-low-density lipoprotein (VLDL), low-density lipoprotein (LDL), high-density lipoprotein (HDL) or acetyl-modified low-density lipoprotein (AcLDL). CM, VLDL, LDL and AcLDL induced LIF secretion which was absent in nonstimulated cells. CM, VLDL, and LDL did not affect IL-1 alpha secretion. CM stimulated IL-8 > TNF-alpha > IL-1 alpha > IL-2 = IFN-gamma, and decreased seventeen-fold GM-CSF secretion. VLDL stimulated IL-8 secretion > IL-1 alpha = IL-2 > IFN-gamma > TNF-alpha and decreased fivefold GM-CSF secretion. LDL stimulated IL-8 secretion > IL-1 alpha > IL-2 = IFN-gamma, it did not modify TNF-alpha and inhibited five hundred-fold GM-CSF secretion. HDL stimulated IL-2 secretion = IFN-gamma > IL-8, it decreased GM-CSF secretion > IL-1 alpha > IL-1 beta > TNF-alpha without affecting LIF. AcLDL stimulated IL-8 secretion > TNF-alpha > IL-1 alpha > IL-2 = IFN-gamma = IL-1 beta, and decreased GM-CSF secretion eightfold. When NK cells were primed with 10, 100 or 500 IU/ml of IL-2 before the addition of lipoproteins, a decrease in the secretion of cytokines was observed as compared with cells primed with IL-2 only. Differences in cytokine secretion were observed among the diverse type of lipoproteins used for cell stimulus. Thus, lipoproteins may condition NK cytokine secretion and cell activation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176105      PMCID: PMC1456702          DOI: 10.1046/j.1365-2567.1997.00174.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  Do vascular wall cytokines promote atherogenesis?

Authors:  P Libby
Journal:  Hosp Pract (Off Ed)       Date:  1992-10-15

Review 2.  Lipoprotein interactions with T cells: an update.

Authors:  K N Traill; L A Huber; G Wick; G Jürgens
Journal:  Immunol Today       Date:  1990-11

3.  Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.

Authors:  S K Basu; J L Goldstein; G W Anderson; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

4.  A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent.

Authors:  M el-Saadani; H Esterbauer; M el-Sayed; M Goher; A Y Nassar; G Jürgens
Journal:  J Lipid Res       Date:  1989-04       Impact factor: 5.922

5.  Plasma lipoproteins and transferrin regulate the proliferation of a continuous T lymphocyte cell line.

Authors:  B M McCarthy; Y Okano; T Nakayasu; M Macy; S R Watson; J A Harmony
Journal:  J Lipid Res       Date:  1987-09       Impact factor: 5.922

6.  Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages.

Authors:  Y J Geng; G K Hansson
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

Review 7.  Immunological mechanisms in atherosclerosis.

Authors:  T Yokota; G K Hansson
Journal:  J Intern Med       Date:  1995-12       Impact factor: 8.989

8.  Receptor-mediated uptake and 'retroendocytosis' of high-density lipoproteins by cholesterol-loaded human monocyte-derived macrophages: possible role in enhancing reverse cholesterol transport.

Authors:  R Alam; F M Yatsu; L Tsui; S Alam
Journal:  Biochim Biophys Acta       Date:  1989-08-22

9.  Expression and function of low-density lipoprotein receptors in CD3-CD16+CD56+ cells: effect of interleukin 2.

Authors:  J B De Sanctis; I Blanca; D Radzioch; N E Bianco
Journal:  Cell Immunol       Date:  1996-01-10       Impact factor: 4.868

Review 10.  Role of human natural killer cells in health and disease.

Authors:  T L Whiteside; R B Herberman
Journal:  Clin Diagn Lab Immunol       Date:  1994-03
View more
  11 in total

1.  Exposures to the environmental toxicants pentachlorophenol (PCP) and dichlorodiphenyltrichloroethane (DDT) modify secretion of interleukin 1-beta (IL-1β) from human immune cells.

Authors:  Tamara J Martin; Margaret M Whalen
Journal:  Arch Toxicol       Date:  2016-09-03       Impact factor: 5.153

2.  Systemic administration of interleukin-2 inhibits inflammatory neutrophil migration: role of nitric oxide.

Authors:  Susana E Moreno; José C Alves-Filho; Giuliana Bertozi; Tais M Alfaya; Jacques Thèze; Sergio H Ferreira; Bernardo Boris Vargaftig
Journal:  Br J Pharmacol       Date:  2006-07-24       Impact factor: 8.739

Review 3.  Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges.

Authors:  Tin Kyaw; Karlheinz Peter; Yi Li; Peter Tipping; Ban-Hock Toh; Alex Bobik
Journal:  Br J Pharmacol       Date:  2017-06-13       Impact factor: 8.739

4.  Soluble NKG2D ligands in the ovarian cancer microenvironment are associated with an adverse clinical outcome and decreased memory effector T cells independent of NKG2D downregulation.

Authors:  Maulik Vyas; Silke Reinartz; Nathalie Hoffmann; Katrin S Reiners; Sonja Lieber; Julia M Jansen; Uwe Wagner; Rolf Müller; Elke Pogge von Strandmann
Journal:  Oncoimmunology       Date:  2017-08-21       Impact factor: 8.110

5.  MICA Expression Is Regulated by Cell Adhesion and Contact in a FAK/Src-Dependent Manner.

Authors:  Gerald Moncayo; Da Lin; Michael T McCarthy; Aleksandra A Watson; Christopher A O'Callaghan
Journal:  Front Immunol       Date:  2017-01-19       Impact factor: 7.561

Review 6.  The IL-2 - IL-2 receptor pathway: Key to understanding multiple sclerosis.

Authors:  Daphne Peerlings; Max Mimpen; Jan Damoiseaux
Journal:  J Transl Autoimmun       Date:  2021-09-21

7.  Synthetic Antibody Mimics Based on Cancer-Targeting Immunostimulatory Peptides.

Authors:  Dante Descalzi-Montoya; Rachel A Montel; Keith Smith; Eugenia Dziopa; Andrieh Darwich; Zheng Yang; Constantine Bitsaktsis; Robert Korngold; David Sabatino
Journal:  Chembiochem       Date:  2020-11-02       Impact factor: 3.164

8.  Dynamics of a cytokine storm.

Authors:  Hao Hong Yiu; Andrea L Graham; Robert F Stengel
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

9.  Decreased inducibility of TNF expression in lipid-loaded macrophages.

Authors:  Mikko P S Ares; Maria Stollenwerk; Anneli Olsson; Bengt Kallin; Stefan Jovinge; Jan Nilsson
Journal:  BMC Immunol       Date:  2002-10-06       Impact factor: 3.615

10.  Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility.

Authors:  Naresh C Laddha; Mitesh Dwivedi; Mohmmad Shoab Mansuri; Mala Singh; Hetanshi H Patel; Nishtha Agarwal; Anish M Shah; Rasheedunnisa Begum
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.